EmailFacebookXLinkedIn

laurence.jocaille_120

About laurence.jocaille_120

This author has not yet filled in any details.
So far laurence.jocaille_120 has created 393 blog entries.

JGO ARTICLE OF THE MONTH – The role of hypomethylating agents in the treatment of elderly patients with AML

2021-07-29T22:38:01+02:00

JGO article of the month (most requested article in January 2016) Haifa Kathrin Al-Ali, Nadja Jaekel, Dietger Niederwieser. Journal of Geriatric Oncology, Vol. 5, Issue 1, p89–105

JGO ARTICLE OF THE MONTH – The role of hypomethylating agents in the treatment of elderly patients with AML2021-07-29T22:38:01+02:00

JGO ARTICLE OF THE MONTH – Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis

2021-07-29T22:38:01+02:00

JGO article of the month (most requested article in December 2015) Chia-Lin Hsu, Jen-Hau Chen, Kuan-Yu Chen, Jin-Yuan Shih, James Chih-Hsin Yang, Chong-Jen Yu, Pan-Chyr Yang. Journal of Geriatric Oncology, Vol. 6, Issue 1

JGO ARTICLE OF THE MONTH – Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis2021-07-29T22:38:01+02:00

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

2021-07-29T22:38:01+02:00

Hulin C, Belch A, Shustik C, Petrucci MT, Dührsen U, Lu J, Song K, Rodon P, Pégourié B, Garderet L, Hunter H, Azais I, Eek R, Gisslinger H, Macro M, Dakhil S, Goncalves C, LeBlanc R, Romeril K, Royer B, Doyen C, Leleu X, Offner F, Leupin N, Houck V, Chen G, Ervin-Haynes A, Dimopoulos MA, Facon T. J Clin Oncol. 2016 Jun 20. pii: JCO667295. [Epub ahead of print]

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial2021-07-29T22:38:01+02:00

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

2021-07-29T22:38:01+02:00

Hershman DL, Till C, Wright JD, Awad D, Ramsey SD, Barlow WE, Minasian LM, Unger J. J Clin Oncol. 2016 Jun 20. pii: JCO662346. [Epub ahead of print]

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials2021-07-29T22:38:01+02:00

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

2021-07-29T22:38:01+02:00

Magarotto V, Bringhen S, Offidani M, Benevolo G, Patriarca F, Mina R, Falcone AP, De Paoli L, Pietrantuono G, Gentili S, Musolino C, Giuliani N, Bernardini A, Conticello C, Pulini S, Ciccone G, Maisnar V, Ruggeri M, Zambello R, Guglielmelli T, Ledda A, Liberati AM, Montefusco V, Hajek R, Boccadoro M, Palumbo A. Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4.

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma2021-07-29T22:38:01+02:00

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen

2021-07-29T22:38:01+02:00

Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, Champlin RE, Chen YB, Vij R, Slack J, Soiffer RJ, Larson RA, Shea TC, Hars V, Sibley AB, Giralt S, Carter S, Horowitz MM, Linker C, Alyea EP. J Clin Oncol. 2015 Dec 10;33(35):4167-75. doi: 10.1200/JCO.2015.62.7273. Epub 2015 Nov 2.

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen2021-07-29T22:38:01+02:00

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small- Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC- GECP 08-02 Study

2021-07-29T22:38:01+02:00

Corre R, Greillier L, Le Caër H, Audigier-Valette C, Baize N, Bérard H, Falchero L, Monnet I, Dansin E, Vergnenègre A, Marcq M, Decroisette C, Auliac JB, Bota S, Lamy R, Massuti B, Dujon C, Pérol M, Daurès JP, Descourt R, Léna H, Plassot C, Chouaïd C. J Clin Oncol. 2016 May 1;34(13):1476-83. doi: 10.1200/JCO.2015.63.5839. Epub 2016 Feb 16.

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small- Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC- GECP 08-02 Study2021-07-29T22:38:01+02:00

Stay in touch and share our news!

SIOG Head Office

  • International Society of Geriatric Oncology
    P/A Comptabilis
    9 route des Jeunes
    1227 Les Acacias - Switzerland

  • +41 22 734 73 43
  • enquiry@siog.org

ECOSOC Special

In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).

Quick links

 

Subscribe to our newsletter

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Go to Top